Meanwhile, paclitaxel—a microtubule-targeting agent commonly used in cancer chemotherapy—has recently been found to enhance Piezo2 signaling responses, thereby participating in the regulation of the tumor microenvironment (63, 74, 75). This evidence concerns the gene PIEZO2 and neoplasm.